|
US2018221678A1
|
|
Closed loop organ stimulation
|
|
CN107921263A
|
|
GI irritation device and application thereof
|
|
US2011256123A1
|
|
Methods for decreasing leptin levels or activity for treating inflammation
|
|
US2012148547A1
|
|
Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
|
|
US2007184058A1
|
|
Glucocerebroside treatment of pulmonary or respiratory diseases or disorders
|
|
IL178821D0
|
|
Direct and indirect modulation of composition and structure of cell membrane by ??-glycolipids
|
|
IL177609D0
|
|
Use of gabaculine or its analog in the manufacture of a medicament for treating hepatocellular carcinoma
|
|
US2006257932A1
|
|
Treatment of Crohn's disease
|
|
US2006079443A1
|
|
Methods and uses of leptin in immune modulation
|
|
US9717754B2
|
|
Glucocerebroside treatment of disease
|
